Search Results - "Vulf, M. A."

Contribution of Adipokine Gene Expression in Mesenteric Adipose Tissue to the Pathogenesis of Insulin Resistance in Obese Patients by Vulf (Vasilenko), M. A., Skuratovskaia, D. A., Kirienkova, E. V., Zatolokin, P. A., Mironyuk, N. I., Litvinova, L. S.

“…Mesenteric adipose tissue, being a component of visceral adipose tissue, has a high lipolytic activity. Excessive accumulation of visceral adipose tissue…”
Get full text

HEPATIC SOD1 GENE EXPRESSION CHANGES IN THE NAFLD PATHOGENESIS IN OBESITY by Komar, A. A., Shunkina (Skuratovsvkaia), D. A., Vulf, M. A., Vu, H. Q., Todosenko, N. M., Zatolokin, P. A., Kirienkova, E. V., Gazatova, N. D., Litvinova, L. S.

“…Steatosis in the liver in obesity increases the work of mitochondria to utilize excess lipids. An overload of β-oxidation of fatty acids, the tricarboxylic…”
Get full text

CHEMERIN AS A POTENTIAL REGULATOR OF MITOCHONDRIAL QUALITY CONTROL IN OBESE PATIENTS by Vulf, M. A., Shunkina (Skuratovskaia), D. A., Hung, V., Komar, A. A., Zatolokin, P. A., Kirienkova, E. V., Gazatova, N. D., Litvinova, L. S.

“…In obese patients, the relationship between the content of chemerin in blood plasma and the expression of genes TFAM, Drp1, MFN2, SOD, BAX, responsible for…”
Get full text

The role of sTNFSF14 in the liver mitochondrial dynamics in obese patients by Komar, A. A., Skuratovskaia, D. A., Vulf, M. A., Vu, H. Q., Darinskas, A., Gazatova, N. D., Todosenko, N. M., Zatolokin, P. A., Kirienkova, E. V., Litvinova, L. S.

“…Background. The pathogenesis of nonalcoholic fatty liver disease (NAFLD), which develops in obesity and type 2 diabetes mellitus (T2DM), is associated with the…”
Get full text

The Role of Single Nucleotide Polymorphisms in the GIPR Gene in Regulation of Secretion of Hormones and Adipokines in Obese Patients with Type 2 Diabetes Mellitus by Skuratovskaia, D. A., Vulf, M. A., Kirienkova, E. V., Mironyuk, N. I., Zatolokin, P. A., Litvinova, L. S.

“…The relationship between the rs2302382, rs8111428 and Glu354Gln (rs1800437) polymorphisms in the GIPR (glucose-dependent insulinotropic polypeptide receptor)…”
Get full text

Features of cellular immunity and regeneration for alcoholic fibrosis of the liver by Gazatova, N. D., Yurova, K. A., Gavrilov, D. V., Vulf, M. A., Novitskii, V. V., Todosenko, N. M., Litvinova, L. S.

“…Purpose. The subpopulation composition of peripheral blood lymphocytes was evaluated in patients with alcoholic liver fibrosis (ALF). Materials and methods…”
Get full text

Factors Governing Development of Non-Alcoholic Fatty Liver Disease and Insulin Resistance in Obesity by Vulf, M. A., Kirienkova, E. V., Skuratovskaia, D. A., Levada, E. V., Volkova, L. V., Zatolokin, P. A., Gazatova, N. D., Litvinova, L. S.

“…— The factors promoting development of non-alcoholic fatty liver disease in patients with obesity and different state of carbohydrate metabolism have been…”
Get full text

Factors governing development of nonalcoholic fatty liver disease and insulin resistance in obesity by Vulf, M A, Kirienkova, E V, Skuratovskaia, D A, Levada, E V, Volkova, L V, Zatolokin, P A, Gazatova, N D, Litvinova, L S

“…The factors promoting development of non-alcoholic fatty liver disease in patients with obesity and different state of carbohydrate metabolism have been…”
Get more information